Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Medrxiv : the Preprint Server for Health Sciences|April 6, 2021
De novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic ResponseAkshay Kothakonda, Lyla Atta, Deborah Plana, et al.
Frontiers in Bioengineering and Biotechnology|September 23, 2021
De Novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic ResponseAkshay Kothakonda, Lyla Atta, Deborah Plana, et al.
Plos Pathogens|December 2, 2021
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationChris Davis, Nicola Logan, Grace Tyson, et al.
Journal of Hematology & Oncology|January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemiaHelen Parry, Graham McIlroy, Rachel Bruton, et al.
The Lancet. Microbe|June 18, 2024
Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort studyLucrèce Ahovègbé, Rajiv Shah, Aboudou Raïmi Kpossou, et al.
Trials|November 20, 2024
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteersVanessa Meier-Stephenson, Michael T Hawkes, Catherine Burton, et al.
Plos Biology|December 21, 2021
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defensesVanessa Herder, Kieran Dee, Joanna K Wojtus, et al.
Journal of Viral Hepatitis|January 25, 2022
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmissionAlexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
Hepatology (Baltimore, Md.)|November 3, 2018
Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral TreatmentsChris Davis, George S Mgomella, Ana da Silva Filipe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity ReportChris Davis, Tom Tipton, Suleman Sabir, et al.
Pageof 24